BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ewe A, Noske S, Karimov M, Aigner A. Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery. Pharmaceutics 2019;11:E600. [PMID: 31726756 DOI: 10.3390/pharmaceutics11110600] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Jin Y, Adams F, Möller J, Isert L, Zimmermann CM, Keul D, Merkel OM. Synthesis and Application of Low Molecular Weight PEI-Based Copolymers for siRNA Delivery with Smart Polymer Blends. Macromol Biosci 2023;23:e2200409. [PMID: 36446588 DOI: 10.1002/mabi.202200409] [Reference Citation Analysis]
2 Karimov M, Scherer M, Franke H, Ewe A, Aigner A. Analysis of polymeric nanoparticle properties for siRNA/DNA delivery in a tumor xenograft tissue slice air-liquid interface model. Biotechnol J 2022;:e2200415. [PMID: 36541426 DOI: 10.1002/biot.202200415] [Reference Citation Analysis]
3 Kubczak M, Michlewska S, Karimov M, Ewe A, Aigner A, Bryszewska M, Ionov M. Comparison of tyrosine-modified low molecular weight branched and linear polyethylenimines for siRNA delivery. Nanotoxicology 2022;16:867-82. [PMID: 36697400 DOI: 10.1080/17435390.2022.2159891] [Reference Citation Analysis]
4 Kandasamy G, Maity D. Current Advancements in Self-assembling Nanocarriers-Based siRNA Delivery for Cancer Therapy. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.113002] [Reference Citation Analysis]
5 Yue L, Ting Y, Long-zhe H, Li-li J, Yong J, Ji-shan Q. Development of a non-viral gene vector for enhancing gene transfection efficiency. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103669] [Reference Citation Analysis]
6 George R, Hehlgans S, Fleischmann M, Rödel C, Fokas E, Rödel F. Advances in nanotechnology-based platforms for survivin-targeted drug discovery. Expert Opin Drug Discov 2022. [PMID: 35593177 DOI: 10.1080/17460441.2022.2077329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Byun MJ, Lim J, Kim S, Park D, Kim T, Park W, Park CG. Advances in Nanoparticles for Effective Delivery of RNA Therapeutics. BioChip J. [DOI: 10.1007/s13206-022-00052-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kubczak M, Michlewska S, Karimov M, Ewe A, Noske S, Aigner A, Bryszewska M, Ionov M. Unmodified and tyrosine-modified polyethylenimines as potential carriers for siRNA: Biophysical characterization and toxicity. Int J Pharm 2022;614:121468. [PMID: 35031413 DOI: 10.1016/j.ijpharm.2022.121468] [Reference Citation Analysis]
9 Noske S, Karimov M, Hansen M, Zatula N, Ewe A, Aigner A. Non-viral siRNA transfection of primary mesenchymal stromal cells (MSCs): Assessment of tyrosine-modified PEI and PPI efficacy and biocompatibility. Int J Pharm 2022;612:121359. [PMID: 34896217 DOI: 10.1016/j.ijpharm.2021.121359] [Reference Citation Analysis]
10 Gong G, Tang X, Zhang J, Liang X, Yang J, Li Q. Phenylboronic Acid-Modified Polyamidoamine Mediated the Transfection of Polo-Like Kinase-1 siRNA to Achieve an Anti-Tumor Efficacy. Int J Nanomedicine 2021;16:8037-48. [PMID: 34934312 DOI: 10.2147/IJN.S329433] [Reference Citation Analysis]
11 Karimov M, Schulz M, Kahl T, Noske S, Kubczak M, Gockel I, Thieme R, Büch T, Reinert A, Ionov M, Bryszewska M, Franke H, Krügel U, Ewe A, Aigner A. Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo. Nanomedicine 2021;36:102403. [PMID: 33932594 DOI: 10.1016/j.nano.2021.102403] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
12 Liu X, Chen L, Zhang Y, Xin X, Qi L, Jin M, Guan Y, Gao Z, Huang W. Enhancing anti-melanoma outcomes in mice using novel chitooligosaccharide nanoparticles loaded with therapeutic survivin-targeted siRNA. European Journal of Pharmaceutical Sciences 2021;158:105641. [DOI: 10.1016/j.ejps.2020.105641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Karimov M, Appelhans D, Ewe A, Aigner A. The combined disulfide cross-linking and tyrosine-modification of very low molecular weight linear PEI synergistically enhances transfection efficacies and improves biocompatibility. Eur J Pharm Biopharm 2021;161:56-65. [PMID: 33582186 DOI: 10.1016/j.ejpb.2021.02.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Fischer D, Dusek N, Hotzel K, Heinze T. The Role of Formamidine Groups in Dextran Based Nonviral Vectors for Gene Delivery on Their Physicochemical and Biological Characteristics. Macromol Biosci 2021;21:e2000220. [PMID: 33025658 DOI: 10.1002/mabi.202000220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Noske S, Karimov M, Aigner A, Ewe A. Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Knockdown. Nanomaterials (Basel) 2020;10:E1809. [PMID: 32927826 DOI: 10.3390/nano10091809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Müller S, Wedler A, Breuer J, Glaß M, Bley N, Lederer M, Haase J, Misiak C, Fuchs T, Ottmann A, Schmachtel T, Shalamova L, Ewe A, Aigner A, Rossbach O, Hüttelmaier S. Synthetic circular miR-21 RNA decoys enhance tumor suppressor expression and impair tumor growth in mice. NAR Cancer 2020;2:zcaa014. [PMID: 34316687 DOI: 10.1093/narcan/zcaa014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Lamberti G, Barba AA. Drug Delivery of siRNA Therapeutics. Pharmaceutics 2020;12:E178. [PMID: 32093141 DOI: 10.3390/pharmaceutics12020178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]